 NORCROSS, Ga., Nov. 28, 2022 GLOBE NEWSWIRE -- Galectin Therapeutics Inc. NASDAQ: GALT, the leading developer of therapeutics that target galectin proteins, announced today the Company will be presenting at the 6th Obesity and NASH Drug Development Summit in Boston, MA. 